| 270) at, in regions hit hardest by the crisis (compared to less-affected regions), trust |
| 271) Compared to Alabama, North Carolina had ha |
| 272) Compared to Calatrava, Gonzaga demonstrate |
| 273) Compared to Gelatin-PS, the two hydrogels |
| 274) Compared to PL, the IT administration of B |
| 275) Compared to ceramic scaffolds, the authors |
| 276) Compared to college females, college males |
| 277) Compared to controls, ACE2 and Mas recepto |
| 278) Compared to controls, electrostimulated ce |
| 279) Compared to eukaryotic cells, viruses are |
| 280) Compared to insulin, GLP-1 appears to be a |
| 281) Compared to non-periodic white noises, per |
| 282) ic genetic diversity of 0-0.97% for nad1, compared to 0-0.42% for ITS-2. |
| 283) ucing memory impairment in rats (2 mg/kg) compared to 0.5 or 1 mg/kg dose. |
| 284) as 21.1 and 28.4% in the US respectively, compared to 11.5 and 12.9% in MX (p < 0 |
| 285) side effects and treatment outcomes were compared to 14 contemporary control patien |
| 286) dian DFI for the study group was 185 days compared to 172 days for the control group |
| 287) quely in 6 to 12 months before death when compared to 18 to 24 months before death. |
| 288) at 60.1% activation in the same test case compared to 19.2% activation using default |
| 289) % of patients who received reconstruction compared to 23.3% in patients who did not |
| 290) The MST of the study group was 311 days compared to 294 days for the control group |
| 291) women reported lowest HPV knowledge when compared to 2nd and 3rd generation women. |
| 292) ly 22% degradation based on mass loss, as compared to 34% for uncrosslinked mats at |
| 293) % (SE) in the 0 tungstate (control) group compared to 4.44 ± 1.42% in the 200 |
| 294) fferent for ASD with comorbid ADHD (ASD+) compared to ADHD. |
| 295) lar chondrocytes (HACs) was evaluated and compared to ASCs. |
| 296) res, BM-MSCs/HUVECs enhanced osteogenesis compared to BM-MSCs monocultures in both F |
| 297) tivity and proliferation increased in PL- compared to FBS-supplemented media in mono |
| 298) eight loss in the GG-MA/HA-GG formulation compared to GG-MA hydrogel. |
| 299) 4 was more potent and of broader spectrum compared to GS-424044. |
| 300) venly to bone adjacent to an implant when compared to H abutment, for both analysis |
| 301) to alcohol at a moderate (2 g/kg) dose compared to HS mice, but did not differ on |
| 302) ays a greater challenge for the clinician compared to MRSA infections. |
| |